Author:
Humphries Brittany,Cox Jafna L,Parkash Ratika,Thabane Lehana,Foster Gary A,MacKillop James,Nemis-White Joanna,Hamilton Laura,Ciaccia Antonio,Choudhri Shurjeel H,Kovic Bruno,Xie Feng
Abstract
Abstract
Background
IMPACT-AF is a prospective, randomized, cluster design trial comparing atrial fibrillation (AF) management with a computerized decision support system (CDS) to usual care (control) in the primary care setting of Nova Scotia, Canada. The objective of this analysis was to compare the resource use and costs between CDS and usual care groups.
Methods
Case costing data, 12-month self-administered questionnaires, and monthly diaries from IMPACT-AF were used in this analysis. Descriptive statistics were used to compare costs and resource use between groups. All costs are presented in 2021 Canadian dollars and cover the 12-month period of participation in the study.
Results
A total of 1,145 patients enrolled in the trial. Case costing data were available for 466 participants (41.1%), 12-month self-administered questionnaire data for 635 participants (56.0%) and monthly diary data for 223 participants (19.7%). Emergency department visits and hospitalizations comprised the most expensive component of AF care. Across all three datasets, there were no statistically significant differences in costs or resource use between CDS and usual care groups.
Conclusions
Although there were no significant differences in resource use or costs among CDS and usual care groups in the IMPACT-AF trial, this study provides insight into the methodology and practical challenges of collecting economic data alongside a trial.
Registration
Clinicaltrials.gov (registration number: NCT01927367, date of registration: 2013-08-20).
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Health Policy,Computer Science Applications
Reference22 articles.
1. Atrial fibrillation. Heart & Stroke Foundation of Canada. [cited 2021 August 14]. Available from: https://www.heartandstroke.ca/heart/conditions/atrial-fibrillation.
2. Humphries KH, Jackevicius C, Gong Y, Svensen L, Cox J, Tu JV, et al. Population rates of hospitalization for atrial fibrillation/flutter in Canada. Can J Cardiol. 2004;20(9):869–76.
3. O’Reilly DJ, Hopkins RB, Healey JS, Dorian P, Sauriol L, Tarride J-E, et al. The Burden of Atrial Fibrillation on the Hospital Sector in Canada. Can J Cardiol. 2013;29(2):229–35.
4. Wodchis WP, Bhatia RS, Leblanc K, Meshkat N, Morra D. A review of the cost of atrial fibrillation. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research. 2012;15(2):240–8.
5. Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC, et al. The 2020 canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the management of Atrial Fibrillation. Can J Cardiol. 2020;36(12):1847–948.